<?xml version="1.0" encoding="UTF-8"?>
<p id="Par29">TB is treatable and curable, generally with four antimicrobial drugs over a 6 month period. Over 30 million lives were saved through effective diagnosis and treatment between 2000 and 2013. Without proper supervision and technical support, adherence to the treatment can be difficult. There is also a growing concern about multidrug-resistant tuberculosis (MDR-TB), i.e., bacteria that do not respond to the most common, first-line drugs. This may be caused by ineffective treatment, either via incorrect use or low quality TB drugs and non-adherence to treatment. MDR-TB is more complex to treat, with lower cure rates, and the costs are 100 times greater than normal TB (WHO 
 <xref ref-type="bibr" rid="CR42">2014e</xref>).
</p>
